# SalvaRx Group PLC

> SalvaRx Group PLC is a VC fund in Ramsey backing Biopharma and Therapeutics. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Ramsey, United Kingdom
- Total investments: 1
- Last investment: Jun 2016
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.3legsresources.com

SalvaRx Group PLC is a VC fund in Ramsey focused on Biopharma and Therapeutics. SalvaRx Group plc, formerly 3Legs Resources plc, is an investing company. The Company is engaged in drug discovery and development, focused on immune-oncology. The Company's segment is appraisal of investment targets meeting the Company's investment policy. The Company is focused on evaluation and assessment of investment opportunities inline with the investment policy. Its product is IMM60. It expects the study to evaluate approximately three treatment groups: a control arm using the standard of care (an anti-programmed death (PD)-1 therapy), a trial arm using iOX Therapeutics Ltd's drug (IMM60), and a third arm that will test the combination of IMM60 and an anti-PD1 therapy. 3Legs Management Services US LLC is the subsidiary of the Company.

## Contacts

5 contacts available for SalvaRx Group PLC. Shizune tracks 1 team members at SalvaRx Group PLC. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/salvarx-group-plc?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ian B. Walters | CEO & Director | 0 | https://shizune.co/investors/profile/ian-b-walters |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Intensity Therapeutics | Intensity Therapeutics, Inc., a biopharmaceutical company, provides chemotherapy treatments for cancer patients. It engages in the direct intratumoral injection of novel pharmaceutical formulations for cancer administration. Intensity Therapeutics, Inc. was incorporated in 2012 and is based in Norwalk, Connecticut. | $10M | Series A | Jun 28, 2016 |  |

1 of 1 investments shown.

## Co-investors
- [Batterson Venture Capital](https://shizune.co/investors/profile/batterson-venture-capita) — VC Fund, 1 deal together
- [VCapital](https://shizune.co/investors/profile/vcapital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does SalvaRx Group PLC invest in?

SalvaRx Group PLC invests primarily in Biopharma, Therapeutics and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact SalvaRx Group PLC?

Public channels for SalvaRx Group PLC include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at SalvaRx Group PLC?

The team at SalvaRx Group PLC includes Ian B. Walters (CEO & Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co